Company

PolyPid Ltd.

Headquarters: Petah Tikva, Israel

Employees: 75

CEO: Mr. Amir Weisberg

NASDAQ: PYPD -3.06%

Market Cap

$12.8 Million

USD as of Jan. 1, 2024

Market Cap History

PolyPid Ltd. market capitalization over time

Evolution of PolyPid Ltd. market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of PolyPid Ltd.

Detailed Description

PolyPid Ltd., a late-stage biopharma company, develops, manufactures, and commercializes products based on polymer-lipid encapsulation matrix (PLEX) platform to address unmet medical needs. Its lead product includes D-PLEX100, which is in Phase 3 clinical trial for the prevention of sternal (bone) surgical site infections (SSIs), as well as for the prevention of abdominal (soft tissue) SSIs. PolyPid Ltd. was incorporated in 2008 and is headquartered in Petah Tikva, Israel.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

PolyPid Ltd. has the following listings and related stock indices.


Stock: NASDAQ: PYPD wb_incandescent

Details

Headquarters:

18 Hasivim Street

PO Box 7126

Petah Tikva, 4959376

Israel

Phone: 972 7 4719 5700

Fax: 972 7 4719 5718